Viridian Therapeutics, Inc.\DE (VRDN) Capital Expenditures (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) reported Capital Expenditures of $1.31 million for Q2 2026, compared with $42,000 a year earlier.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Capital Expenditures (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viridian Therapeutics, Inc.\DE's Capital Expenditures came in at $1.7 million, up 217.0% year-over-year; for FY2025, it came in at $495,000, down 3.1% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 63.8% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $511,000 in FY2024 (-43.1%), $898,000 in FY2023 (+12.7%), $797,000 in FY2022 (+135.8%) and $338,000 in FY2021 (+704.8%).
- The Q2 2026 figure ranks as the highest quarterly Capital Expenditures in data going back to Q4 2013.
- Year over year, Capital Expenditures gained in two of the last six quarters, with growth averaging 5.2%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 440.7%); the low point was Q4 2023 (a decline of 79.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $23,000 (Q1 2026), $240,000 (Q4 2025) and $127,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.39 Bn | -714.87 Mn | - | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 240,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 404,000.00 |
| Jun 30, 2023 | 331,000.00 |
| Mar 31, 2023 | 115,000.00 |
| Dec 31, 2022 | 231,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 179,000.00 |
| Dec 31, 2021 | 84,000.00 |
| Sep 30, 2021 | 185,000.00 |
| Jun 30, 2021 | 54,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();